Towards Healthcare
Filtration in Biologics Market Accelerates in 2025 with Thermo Fisher’s $4.1...

Filtration in Biologics Market Growth and Competitive Landscape in 2025

According to market projections, the global filtration in biologics market is fueled by growing demand for biologics such as vaccines and therapies for cancer and autoimmune disorders, and by boosting investments in R&D activities. Whereas, North America was dominant with a major share of the market, due to increasing growth in biologics and the enforcement of strict regulatory guidelines. 

Content

  • Insight Code: 5798
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

Explore the Filtration in Biologics Market trends from 2024 to 2034, driven by rising biologics demand, single-use systems, and regulatory compliance.

North America is currently leading the filtration in biologics market due to the expansion of biologics and stringent regulatory considerations in filtration processes.

The filtration in biologics market includes 6 segments, such as by filtration type, by product type, by biologic, by process stage, by end-user, and by region etc.

Some key players include Merck KGaA (MilliporeSigma), Sartorius AG, Danaher Corporation (Cytiva & Pall Life Sciences), Thermo Fisher Scientific, and 3M Health Care (formerly Purification Solutions).

Key trends include rising demand for biologics, biosimilars, and personalized medicine, growth in R&D activities, and innovation in filtration technologies, vaccines.

Biopharmaceutical filtration is the process of separation and purification of biological products, such as proteins, antibodies, and vaccines, using different filtration systems.

The key considerations in selecting a filtration system are pore size, filter material, surface area, sample viscosity, temperature, and prefiltration.

Equipment required for filtration includes syringe filters, disc membranes, and vacuum filters.

NIH.GOV, CDC.GOV, US FDA.GOV, NCI.GOV, PIB.GOV, GOV.UK, OREGON.GOV, US EPA.GOV
Any Questions